Contact Us
Drug Search Results
More Filters [+]

Threonine

Alternative Names: threonine, clinimix, plenamine, clinimix e, travasol, premasol - sulfite-free (amino acid), freamine iii, trophamine, aminosyn ii, hepatamine, aminosyn-pf, procalamine, prosol, clinisol, kabiven, perikabiven
Latest Update: 2024-08-26
Latest Update Note: News Article

Product Description

Mechanisms of Action: Protein Synthesis Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Australia | Austria | Bangladesh | Belgium | Bosnia | Brazil | Chile | China | Croatia | Cyprus | Egypt | Finland | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Israel | Lebanon | Malaysia | Malta | Netherlands | New Zealand | Norway | Pakistan | Poland | Russia | Serbia | South Africa | Spain | Sweden | Taiwan | Thailand | Turkey | Ukraine | United Arab Emirates | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Baxter Healthcare
Company Location: DEERFIELD IL 60015
Company CEO: José E. Almeida
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Threonine

Countries in Clinic: United States

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Muscle Weakness

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
SeND Home

P2

Recruiting

Muscle Weakness

2024-09-30

Recent News Events

Date

Type

Title

08/26/2024

News Article

 Amino Acid Market to Grow by USD 12.70 Billion from 2024 to 2028, Driven by Rising Demand in Sports Supplements, AI-Enhanced Market Evolution- Report by Technavio

07/15/2024

News Article

 Cytonics Announces Initiation Of First-In-Human Phase 1 Clinical Study For CYT-108 In Patients Suffering From Osteoarthritis Of The Knee

06/26/2024

News Article

 Alzheimer's Disease Blood Biomarkers Identified in New Feinstein Institutes Study

06/04/2024

News Article

 Promega Contributes to New Study on Reversible, Non-Hormonal Male Contraception

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions